Jonathan S. Duke-Cohan, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hair Color | 2 | 2020 | 140 | 0.920 |
Why?
|
| Cell Dedifferentiation | 1 | 2022 | 138 | 0.850 |
Why?
|
| Exocytosis | 1 | 2020 | 362 | 0.690 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2022 | 1396 | 0.630 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2022 | 2480 | 0.620 |
Why?
|
| Proteoglycans | 1 | 2020 | 831 | 0.620 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 5 | 2021 | 802 | 0.540 |
Why?
|
| GTPase-Activating Proteins | 1 | 2018 | 492 | 0.530 |
Why?
|
| Membrane Proteins | 7 | 2020 | 8047 | 0.500 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 1754 | 0.440 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 951 | 0.430 |
Why?
|
| Smallpox Vaccine | 2 | 2009 | 77 | 0.430 |
Why?
|
| Protein Array Analysis | 3 | 2011 | 412 | 0.420 |
Why?
|
| Semaphorins | 6 | 2018 | 117 | 0.410 |
Why?
|
| Vaccinia virus | 2 | 2009 | 345 | 0.390 |
Why?
|
| Glycoproteins | 4 | 2018 | 2306 | 0.300 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 2100 | 0.290 |
Why?
|
| Antigens, Viral | 3 | 2012 | 1159 | 0.290 |
Why?
|
| Thymus Gland | 4 | 2022 | 1317 | 0.280 |
Why?
|
| Membrane Microdomains | 1 | 2006 | 210 | 0.280 |
Why?
|
| Complementarity Determining Regions | 2 | 2016 | 159 | 0.280 |
Why?
|
| Mice, Knockout | 7 | 2022 | 15058 | 0.250 |
Why?
|
| Mice, Inbred C3H | 2 | 2020 | 1013 | 0.240 |
Why?
|
| Histocompatibility Antigens | 3 | 2019 | 527 | 0.240 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2020 | 158 | 0.200 |
Why?
|
| Antibodies, Bispecific | 1 | 2022 | 147 | 0.190 |
Why?
|
| Melanoma-Specific Antigens | 1 | 2019 | 82 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2021 | 329 | 0.180 |
Why?
|
| Agouti Signaling Protein | 1 | 2019 | 26 | 0.180 |
Why?
|
| Peromyscus | 1 | 2019 | 16 | 0.180 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2021 | 522 | 0.180 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2020 | 269 | 0.170 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 3 | 2016 | 259 | 0.170 |
Why?
|
| Antibodies, Viral | 2 | 2009 | 2995 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 4 | 2018 | 1413 | 0.170 |
Why?
|
| Cell Adhesion | 3 | 2018 | 3265 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 4 | 2018 | 4561 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2018 | 2977 | 0.160 |
Why?
|
| Pyroglyphidae | 1 | 2017 | 85 | 0.160 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2018 | 249 | 0.150 |
Why?
|
| Cell Movement | 4 | 2018 | 5397 | 0.150 |
Why?
|
| Mice | 13 | 2022 | 80373 | 0.150 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2021 | 354 | 0.150 |
Why?
|
| HIV Seropositivity | 1 | 2022 | 914 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2006 | 2538 | 0.150 |
Why?
|
| Membrane Glycoproteins | 4 | 2018 | 3824 | 0.150 |
Why?
|
| Integrins | 2 | 2018 | 829 | 0.150 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2019 | 513 | 0.140 |
Why?
|
| Peptides | 3 | 2022 | 4384 | 0.140 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2019 | 871 | 0.140 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 287 | 0.140 |
Why?
|
| Animals | 19 | 2022 | 169404 | 0.130 |
Why?
|
| Ligands | 5 | 2021 | 3294 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1046 | 0.120 |
Why?
|
| Selection, Genetic | 1 | 2019 | 886 | 0.120 |
Why?
|
| Cell Membrane | 2 | 2018 | 3881 | 0.120 |
Why?
|
| Jurkat Cells | 3 | 2020 | 777 | 0.120 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 12305 | 0.120 |
Why?
|
| Protein Binding | 7 | 2020 | 9558 | 0.110 |
Why?
|
| src Homology Domains | 2 | 2020 | 371 | 0.110 |
Why?
|
| COS Cells | 2 | 2020 | 1201 | 0.100 |
Why?
|
| CD40 Ligand | 1 | 2012 | 521 | 0.100 |
Why?
|
| Validation Studies as Topic | 1 | 2011 | 169 | 0.100 |
Why?
|
| T-Lymphocytes | 5 | 2021 | 10284 | 0.100 |
Why?
|
| Neutralization Tests | 2 | 2009 | 761 | 0.090 |
Why?
|
| Viral Structural Proteins | 1 | 2009 | 104 | 0.090 |
Why?
|
| Protein Multimerization | 3 | 2020 | 997 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3574 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 936 | 0.080 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 4902 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 22663 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 643 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2017 | 6803 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18197 | 0.070 |
Why?
|
| Genes, MHC Class I | 1 | 2007 | 274 | 0.070 |
Why?
|
| Protein Structure, Secondary | 2 | 2021 | 1220 | 0.070 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2005 | 111 | 0.070 |
Why?
|
| Models, Molecular | 4 | 2019 | 5467 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 604 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 2010 | 1842 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2014 | 2313 | 0.070 |
Why?
|
| Kidney | 1 | 2020 | 6882 | 0.070 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2006 | 385 | 0.060 |
Why?
|
| HIV-1 | 1 | 2022 | 6838 | 0.060 |
Why?
|
| Liver | 1 | 2020 | 7594 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2021 | 14161 | 0.060 |
Why?
|
| Demyelinating Diseases | 1 | 2006 | 367 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2020 | 8657 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 9849 | 0.060 |
Why?
|
| Neutrophils | 1 | 2016 | 3800 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 967 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6641 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 1162 | 0.060 |
Why?
|
| Viral Vaccines | 1 | 2009 | 634 | 0.060 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2012 | 1514 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2009 | 6664 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 12540 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2006 | 792 | 0.050 |
Why?
|
| Lymphocytes | 2 | 2011 | 2737 | 0.050 |
Why?
|
| Melanoma | 1 | 2019 | 5250 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2022 | 205 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2007 | 1545 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1821 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2019 | 4041 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2020 | 119 | 0.050 |
Why?
|
| Humans | 23 | 2022 | 715818 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2008 | 1893 | 0.050 |
Why?
|
| Age of Onset | 1 | 2006 | 3316 | 0.050 |
Why?
|
| Nebraska | 1 | 2019 | 38 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2939 | 0.050 |
Why?
|
| Virus Latency | 1 | 2022 | 348 | 0.050 |
Why?
|
| Protein Stability | 1 | 2021 | 567 | 0.050 |
Why?
|
| HLA-A2 Antigen | 1 | 2019 | 227 | 0.050 |
Why?
|
| Lung | 2 | 2017 | 9739 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2015 | 19905 | 0.040 |
Why?
|
| Asthma | 1 | 2017 | 5945 | 0.040 |
Why?
|
| Peptide Library | 1 | 2019 | 342 | 0.040 |
Why?
|
| Pigmentation | 1 | 2019 | 160 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2010 | 2943 | 0.040 |
Why?
|
| Cholesterol | 1 | 2006 | 2866 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2015 | 11655 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 2020 | 1020 | 0.040 |
Why?
|
| Cytokines | 2 | 2017 | 7189 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2006 | 2553 | 0.040 |
Why?
|
| Melanins | 1 | 2019 | 288 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2022 | 4379 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2019 | 3722 | 0.040 |
Why?
|
| Binding Sites | 1 | 2006 | 6213 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2019 | 6093 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9504 | 0.040 |
Why?
|
| HIV Infections | 1 | 2022 | 15784 | 0.040 |
Why?
|
| Airway Remodeling | 1 | 2017 | 142 | 0.040 |
Why?
|
| Administration, Intranasal | 1 | 2017 | 458 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2020 | 1983 | 0.040 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2016 | 248 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 1238 | 0.030 |
Why?
|
| Male | 5 | 2020 | 350352 | 0.030 |
Why?
|
| Mutation | 5 | 2019 | 29290 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2019 | 1550 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2019 | 1251 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2016 | 692 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 699 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2020 | 3818 | 0.030 |
Why?
|
| Alleles | 2 | 2019 | 7099 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3206 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 441 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2013 | 339 | 0.030 |
Why?
|
| Models, Immunological | 1 | 2015 | 532 | 0.030 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2016 | 387 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2015 | 5853 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 348 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 2222 | 0.030 |
Why?
|
| Glioma | 1 | 2006 | 3302 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2017 | 1053 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 2014 | 438 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2012 | 289 | 0.030 |
Why?
|
| Viral Matrix Proteins | 1 | 2012 | 281 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2017 | 749 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2013 | 614 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2011 | 5378 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2015 | 2913 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2021 | 23729 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4266 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 16735 | 0.020 |
Why?
|
| Genotype | 2 | 2019 | 12919 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2005 | 3645 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 2012 | 346 | 0.020 |
Why?
|
| Allergens | 1 | 2017 | 1296 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 9809 | 0.020 |
Why?
|
| Fowlpox virus | 1 | 2009 | 20 | 0.020 |
Why?
|
| Chemokines | 1 | 2013 | 962 | 0.020 |
Why?
|
| Receptors, CCR | 1 | 2008 | 36 | 0.020 |
Why?
|
| Defective Viruses | 1 | 2009 | 116 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2010 | 264 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 18591 | 0.020 |
Why?
|
| Actins | 1 | 2016 | 2167 | 0.020 |
Why?
|
| Inflammation | 2 | 2019 | 10082 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2012 | 974 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1890 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 2033 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2009 | 336 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2413 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2009 | 878 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 289 | 0.020 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2006 | 52 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2008 | 1016 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2009 | 634 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2017 | 2699 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2007 | 390 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2009 | 1001 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 8805 | 0.020 |
Why?
|
| Female | 4 | 2018 | 377229 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2008 | 606 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2013 | 2008 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 3687 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2006 | 396 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 976 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4279 | 0.020 |
Why?
|
| Cell Line | 2 | 2009 | 16575 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2011 | 2137 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2466 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2005 | 714 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 1684 | 0.010 |
Why?
|
| AIDS Vaccines | 1 | 2009 | 916 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2009 | 2432 | 0.010 |
Why?
|
| Calcium | 1 | 2015 | 5800 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 2066 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3636 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2005 | 784 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 2766 | 0.010 |
Why?
|
| Antibodies | 1 | 2009 | 2432 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16311 | 0.010 |
Why?
|
| Indoles | 1 | 2009 | 1842 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 1116 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2010 | 2594 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2005 | 1803 | 0.010 |
Why?
|
| Cell Death | 1 | 2006 | 1724 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 4296 | 0.010 |
Why?
|
| Haplotypes | 1 | 2007 | 2885 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2009 | 1922 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6274 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2009 | 2313 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 4492 | 0.010 |
Why?
|
| Prognosis | 2 | 2010 | 29007 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2009 | 3529 | 0.010 |
Why?
|
| Piperazines | 1 | 2009 | 2524 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 4823 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2006 | 3681 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3897 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40032 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2008 | 4152 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 162468 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11689 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 212279 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 9971 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 15603 | 0.000 |
Why?
|
| Middle Aged | 2 | 2010 | 214666 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17409 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 58326 | 0.000 |
Why?
|
| Time Factors | 1 | 2006 | 40887 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2010 | 62040 | 0.000 |
Why?
|